BDBM261824 1-[2-(Dimethylamino)ethyl]-2-(9-ethyl-9H-carbazol-3-yl)-N-[(4-methylphenyl)sulphonyl]-1H-benzimidazole-5-carboxamide::US9708311, 75

SMILES CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCN(C)C)C(=O)NS(=O)(=O)c1ccc(C)cc1

InChI Key InChIKey=QUUUVMYILCYILS-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 261824   

TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM261824(1-[2-(Dimethylamino)ethyl]-2-(9-ethyl-9H-carbazol-...)
Affinity DataIC50:  21.4nMT: 2°CAssay Description:4 μl of a cAMP-d2/cell suspension (625000 cells/ml) were added to a test plate containing the substance solutions already initially introduced (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent